Collaboration or coercion? partnering to divert prescription opioid medications

Journal of Urban Health

Volumn 90, Issue 4, 2013, Pages 758-767

  Green, Traci C ^a,b   Bowman, Sarah E ^a   Ray, Madeline ^a   Zaller, Nickolas ^b,c   Heimer, Robert ^d   Case, Patricia ^e  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d YALE UNIVERSITY   (United States)

^e Fenway Community Health   (United States)

Author keywords

Diversion; Elder abuse; Overdose; Prescription opioid abuse

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; COOPERATION; FEMALE; HUMAN; INTERVIEW; MALE; OPIOID-RELATED DISORDERS; PERSUASIVE COMMUNICATION; PRESCRIPTION DRUG DIVERSION; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; ARTICLE; OPIATE ADDICTION; PSYCHOLOGICAL ASPECT; STATISTICS;

ADULT; ANALGESICS, OPIOID; COERCION; CONNECTICUT; COOPERATIVE BEHAVIOR; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUGS; RHODE ISLAND;

EID: 84881478733     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9784-5     Document Type: Article

References (29)

1. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300: 2613-2620.
2. Paulozzi LJ. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006; 96(10): 1755-1757.
3. Paulozzi LJ, Ballesteros MF, Stevens JA. Recent trends in mortality from unintentional injury in the United States. J Safety Res. 2006; 37(3): 277-283.
4. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15(9): 618-627.
5. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006; 31(6): 506-511.
6. Diversion Prevention and Control, Uniform Controlled Substances Act. In: on NCoC, Laws US, eds. Chicago, Il1994.
7. Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008; 92(1-3): 267-276.
8. Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007; 90(1): 64-71.
9. Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse. 2006; 41(2): 255-264.
10. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007; 8(2): 171-183.
11. Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW. The "black box" of prescription drug diversion. J Addict Dis. 2009; 28(4): 332-347.
12. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009; 10(3): 537-548.
13. Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy. 2012; 23(1): 37-44.
14. Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend. 2011; 115(3): 221-8.
15. SAMHSA. Area profiles of drug-related mortality, 2008. Rockville, MD2010.
16. Advameb, Inc., City-Data. updated July 1, 2012. http://www.city-data.com. Accessed 14 Aug 2012.
17. RADARS System."OxyContin". StreetRx. Updated August 10, 2012. http://www.streetrx.com. Accessed 10 Aug 2012.
18. Cicero TJ, Inciardi JA, Surratt H. Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend. 2007; 91(2-3): 115-120.
19. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008; 17(10): 997-1005.
20. Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007; 16(8): 827-840.
21. Jones DL, Irwin KL, Inciardi J, et al. The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. The Multicenter Crack Cocaine and HIV Infection Study Team. Sex Transm Dis. 1998; 25(4): 187-193.
22. Weatherby NL, Shultz JM, Chitwood DD, et al. Crack cocaine use and sexual activity in Miami, Florida. J Psychoactive Drugs. 1992; 24(4): 373-380.
23. Green TC, Mann MR, Bowman SE, et al. How does use of a prescription monitoring program change medical practice? Pain Med. 2012; 13(10): 1314-23.
24. O'Campo P, Kirst M, Tsamis C, Chambers C, Ahmad F. Implementing successful intimate partner violence screening programs in health care settings: evidence generated from a realist-informed systematic review. Soc Sci Med. 2011; 72(6): 855-866.
25. Ramsay J, Richardson J, Carter YH, Davidson LL, Feder G. Should health professionals screen women for domestic violence? Systematic review. BMJ. 2002; 325(7359): 314.
26. McCaw B, Berman WH, Syme SL, Hunkeler EF. Beyond screening for domestic violence: a systems model approach in a managed care setting. Am J Prev Med. 2001; 21(3): 170-176.
27. Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001; 50(2): 145-151.
28. Fishman SM, Papazian JS, Gonzalez S, Riches PS, Gilson A. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Med. 2004; 5(3): 309-324.
29. Richard M, Reisman PJS, Adam J, Atherly, Christopher R, Flowers. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse Res Treat. 2009; 3: 41-51.